Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K. Wells(Parker Institute for Cancer Immunotherapy), Marit M. van Buuren(The Netherlands Cancer Institute), Kristen K. Dang(Sage Bionetworks), Vanessa M. Hubbard-Lucey, Kathleen C. F. Sheehan(Washington University in St. Louis), Katie M. Campbell(University of California, Los Angeles), Andrew Lamb(Sage Bionetworks), Jeffrey P. Ward(Washington University in St. Louis), John Sidney(La Jolla Institute for Immunology), Ana-Belén Blázquez(Icahn School of Medicine at Mount Sinai), Andrew J. Rech(Hospital of the University of Pennsylvania), Jesse M. Zaretsky(University of California, Los Angeles), Begonya Comin-Anduix(University of California, Los Angeles), Alphonsus H. C. Ng(Institute for Systems Biology), William Chour(California Institute of Technology), Thomas Yu(Sage Bionetworks), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Jia M. Chen(University of California, Los Angeles), Patrice Manning(Parker Institute for Cancer Immunotherapy), Gabriela Steiner(Parker Institute for Cancer Immunotherapy), Xengie Doan(Sage Bionetworks), Aly A. Khan(Cornell University), Amit A. Lugade(Sage Bionetworks), Ana Mijalkovic Lazic(Parker Institute for Cancer Immunotherapy), Angela Frentzen(Parker Institute for Cancer Immunotherapy), Arbel D. Tadmor(University of California, Los Angeles), Ariella Sasson(Memorial Sloan Kettering Cancer Center), Arjun A. Rao(Broad Institute), Baikang Pei(University of California San Diego), Barbara Schrörs(Institute for Systems Biology), Beata Berent-Maoz(Parker Institute for Cancer Immunotherapy), Beatriz M. Carreno(Parker Institute for Cancer Immunotherapy), Bin Song(Washington University in St. Louis), Bjoern Peters(The Netherlands Cancer Institute), Bo Li(The Netherlands Cancer Institute), Brandon W. Higgs(Parker Institute for Cancer Immunotherapy), Brian J. Stevenson, Christian Iseli, Christopher A. Miller, Christopher Morehouse, Cornelis J.M. Melief, Cristina Puig-Saus, Daphne M. van Beek, David Balli, David Gfeller, David Haussler, Dirk Jäger, Eduardo Cortes, Ekaterina Esaulova, Elham Sherafat(Parker Institute for Cancer Immunotherapy), Francisco Arcila, Gábor Bartha, Geng Liu, George Coukos, Guilhem Richard, Chang Han, Han Si, Inka Zörnig, Ioannis Xénarios, Ion Măndoiu, Irsan Kooi, James Conway, Jan H. Kessler, Jason Greenbaum, Jason Perera, Jason Harris, Jasreet Hundal, Jennifer Shelton, Jianmin Wang, Jiaqian Wang, Joel Greshock(Washington University in St. Louis), Jonathon Blake(La Jolla Institute for Immunology), Joseph D. Szustakowski, Julia Kodysh, Juliet Forman, Lei Wei, Leo J. Lee, Lorenzo F. Fanchi, Maarten Slagter, Maren Lang, Markus S. Mueller, Martin Löwer, Mathias Vormehr, Maxim N. Artyomov, Michael Kuziora, Michael F. Princiotta, Michal Bassani‐Sternberg, Mignonette H. Macabali, Milica Kojicic, Naibo Yang, Nevena Ilic Raicevic, Nicolas Guex(Washington University in St. Louis), Nicolas Robine, Niels Halama, Nikola Skundric, Ognjen Milićević, Pascal Gellert, Patrick Jongeneel, Pornpimol Charoentong, Pramod K. Srivastava, Prateek Tanden, Priyanka Shah, Qiang Hu, Ravi Gupta, Richard Chen, Robert G. Petit, Robert Ziman, Rolf Hilker, Sachet A. Shukla, Sahar Al Seesi, Sean M. Boyle, Si Qiu, Siranush Sarkizova, Sofie R. Salama, Song Liu, Song Wu, Sriram Sridhar, Steven L. C. Ketelaars(The Netherlands Cancer Institute), Suchit Jhunjhunwala, Tatiana Shcheglova(University of California, Los Angeles), Thierry Schuepbach(Washington University in St. Louis), Todd Creasy(Washington University in St. Louis), Veliborka Josipovic, Vladimir Kovačević, Weixuan Fu, Willem-Jan Krebber, Yi‐Hsiang Hsu(La Jolla Institute for Immunology), Yinong Sebastian, Zeynep Koşaloğlu, Zhiqin Huang, Taha Merghoub(Cornell University), Justin Guinney(Sage Bionetworks), Adam Kolom(Parker Institute for Cancer Immunotherapy), Cheryl Selinsky(Parker Institute for Cancer Immunotherapy), Antoni Ribas(Parker Institute for Cancer Immunotherapy), Matthew D. Hellmann(Cornell University), Nir Hacohen(Broad Institute), Alessandro Sette(Tisch Hospital), James R. Heath(Parker Institute for Cancer Immunotherapy), Nina Bhardwaj(Parker Institute for Cancer Immunotherapy), Fred Ramsdell(Parker Institute for Cancer Immunotherapy), Robert D. Schreiber(Parker Institute for Cancer Immunotherapy), Ton N. Schumacher(The Netherlands Cancer Institute), Pia Kvistborg(The Netherlands Cancer Institute), Nadine A. Defranoux(Parker Institute for Cancer Immunotherapy)
Cited by 529Open Access